Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Common Equity (2017 - 2020)

enVVeno Medical has reported Common Equity over the past 4 years, most recently at $7.1 million for Q4 2020.

  • For Q4 2020, Common Equity rose 617.01% year-over-year to $7.1 million; the TTM value through Dec 2020 reached $7.1 million, up 617.01%, while the annual FY2020 figure was $7.1 million, 617.01% up from the prior year.
  • Common Equity for Q4 2020 was $7.1 million at enVVeno Medical, up from $4.8 million in the prior quarter.
  • Over five years, Common Equity peaked at $7.1 million in Q4 2020 and troughed at -$15.7 million in Q1 2018.
  • A 4-year average of $550559.3 and a median of $2.9 million in 2019 define the central range for Common Equity.
  • On a YoY basis, Common Equity climbed as much as 617.01% in 2020 and fell as far as 100.51% in 2020.
  • Year by year, Common Equity stood at -$11.1 million in 2017, then skyrocketed by 118.3% to $2.0 million in 2018, then crashed by 51.39% to $989940.0 in 2019, then skyrocketed by 617.01% to $7.1 million in 2020.
  • Business Quant data shows Common Equity for NVNO at $7.1 million in Q4 2020, $4.8 million in Q3 2020, and $369446.0 in Q2 2020.